The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bacterial Vaccines for Humans Market Research Report 2025
Synopsis
A bacterial vaccine is a type of vaccine used to prevent infections caused by bacteria. This type of vaccine works by stimulating the immune system to produce an immune response to a specific bacterium, thereby increasing the body's resistance to that bacterium. Bacterial vaccines usually contain killed or weakened bacteria, their isolated antigens, or their synthesized proteins.
The global Bacterial Vaccines for Humans market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bacterial Vaccines for Humans is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bacterial Vaccines for Humans is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bacterial Vaccines for Humans include Merck, Sanofi, GSK, Mitsubishi Tanabe Pharma, Pfizer, Bayer, Emergent BioSolutions, Walvax and Chengdu Kanghua Biological Products Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bacterial Vaccines for Humans, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacterial Vaccines for Humans.
Report Scope
The Bacterial Vaccines for Humans market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bacterial Vaccines for Humans market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacterial Vaccines for Humans manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Sanofi
GSK
Mitsubishi Tanabe Pharma
Pfizer
Bayer
Emergent BioSolutions
Walvax
Chengdu Kanghua Biological Products Co., Ltd.
Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
Beijing Institute of Biological Products Co., Ltd.
CanSino Biological Co., Ltd.
Hualan Biological Vaccine Co., Ltd.
Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
Segment by Type
Meningococcal Vaccine
Hib Vaccine
BCG Vaccine
Typhoid Vaccine
Anthrax Vaccine
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bacterial Vaccines for Humans manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bacterial Vaccines for Humans in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A bacterial vaccine is a type of vaccine used to prevent infections caused by bacteria. This type of vaccine works by stimulating the immune system to produce an immune response to a specific bacterium, thereby increasing the body's resistance to that bacterium. Bacterial vaccines usually contain killed or weakened bacteria, their isolated antigens, or their synthesized proteins.
The global Bacterial Vaccines for Humans market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bacterial Vaccines for Humans is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bacterial Vaccines for Humans is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bacterial Vaccines for Humans include Merck, Sanofi, GSK, Mitsubishi Tanabe Pharma, Pfizer, Bayer, Emergent BioSolutions, Walvax and Chengdu Kanghua Biological Products Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bacterial Vaccines for Humans, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacterial Vaccines for Humans.
Report Scope
The Bacterial Vaccines for Humans market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bacterial Vaccines for Humans market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacterial Vaccines for Humans manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Sanofi
GSK
Mitsubishi Tanabe Pharma
Pfizer
Bayer
Emergent BioSolutions
Walvax
Chengdu Kanghua Biological Products Co., Ltd.
Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
Beijing Institute of Biological Products Co., Ltd.
CanSino Biological Co., Ltd.
Hualan Biological Vaccine Co., Ltd.
Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
Segment by Type
Meningococcal Vaccine
Hib Vaccine
BCG Vaccine
Typhoid Vaccine
Anthrax Vaccine
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bacterial Vaccines for Humans manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bacterial Vaccines for Humans in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Bacterial Vaccines for Humans Market Overview
1.1 Product Overview and Scope of Bacterial Vaccines for Humans
1.2 Bacterial Vaccines for Humans Segment by Type
1.2.1 Global Bacterial Vaccines for Humans Market Value Comparison by Type (2024-2030)
1.2.2 Meningococcal Vaccine
1.2.3 Hib Vaccine
1.2.4 BCG Vaccine
1.2.5 Typhoid Vaccine
1.2.6 Anthrax Vaccine
1.3 Bacterial Vaccines for Humans Segment by Application
1.3.1 Global Bacterial Vaccines for Humans Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Bacterial Vaccines for Humans Market Size Estimates and Forecasts
1.4.1 Global Bacterial Vaccines for Humans Revenue 2019-2030
1.4.2 Global Bacterial Vaccines for Humans Sales 2019-2030
1.4.3 Global Bacterial Vaccines for Humans Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bacterial Vaccines for Humans Market Competition by Manufacturers
2.1 Global Bacterial Vaccines for Humans Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bacterial Vaccines for Humans Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bacterial Vaccines for Humans Average Price by Manufacturers (2019-2024)
2.4 Global Bacterial Vaccines for Humans Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bacterial Vaccines for Humans, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bacterial Vaccines for Humans, Product Type & Application
2.7 Bacterial Vaccines for Humans Market Competitive Situation and Trends
2.7.1 Bacterial Vaccines for Humans Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bacterial Vaccines for Humans Players Market Share by Revenue
2.7.3 Global Bacterial Vaccines for Humans Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bacterial Vaccines for Humans Retrospective Market Scenario by Region
3.1 Global Bacterial Vaccines for Humans Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bacterial Vaccines for Humans Global Bacterial Vaccines for Humans Sales by Region: 2019-2030
3.2.1 Global Bacterial Vaccines for Humans Sales by Region: 2019-2024
3.2.2 Global Bacterial Vaccines for Humans Sales by Region: 2025-2030
3.3 Global Bacterial Vaccines for Humans Global Bacterial Vaccines for Humans Revenue by Region: 2019-2030
3.3.1 Global Bacterial Vaccines for Humans Revenue by Region: 2019-2024
3.3.2 Global Bacterial Vaccines for Humans Revenue by Region: 2025-2030
3.4 North America Bacterial Vaccines for Humans Market Facts & Figures by Country
3.4.1 North America Bacterial Vaccines for Humans Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bacterial Vaccines for Humans Sales by Country (2019-2030)
3.4.3 North America Bacterial Vaccines for Humans Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bacterial Vaccines for Humans Market Facts & Figures by Country
3.5.1 Europe Bacterial Vaccines for Humans Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bacterial Vaccines for Humans Sales by Country (2019-2030)
3.5.3 Europe Bacterial Vaccines for Humans Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Bacterial Vaccines for Humans Market Facts & Figures by Country
3.6.1 Asia Pacific Bacterial Vaccines for Humans Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bacterial Vaccines for Humans Sales by Country (2019-2030)
3.6.3 Asia Pacific Bacterial Vaccines for Humans Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Bacterial Vaccines for Humans Market Facts & Figures by Country
3.7.1 Latin America Bacterial Vaccines for Humans Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bacterial Vaccines for Humans Sales by Country (2019-2030)
3.7.3 Latin America Bacterial Vaccines for Humans Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bacterial Vaccines for Humans Market Facts & Figures by Country
3.8.1 Middle East and Africa Bacterial Vaccines for Humans Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bacterial Vaccines for Humans Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bacterial Vaccines for Humans Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bacterial Vaccines for Humans Sales by Type (2019-2030)
4.1.1 Global Bacterial Vaccines for Humans Sales by Type (2019-2024)
4.1.2 Global Bacterial Vaccines for Humans Sales by Type (2025-2030)
4.1.3 Global Bacterial Vaccines for Humans Sales Market Share by Type (2019-2030)
4.2 Global Bacterial Vaccines for Humans Revenue by Type (2019-2030)
4.2.1 Global Bacterial Vaccines for Humans Revenue by Type (2019-2024)
4.2.2 Global Bacterial Vaccines for Humans Revenue by Type (2025-2030)
4.2.3 Global Bacterial Vaccines for Humans Revenue Market Share by Type (2019-2030)
4.3 Global Bacterial Vaccines for Humans Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bacterial Vaccines for Humans Sales by Application (2019-2030)
5.1.1 Global Bacterial Vaccines for Humans Sales by Application (2019-2024)
5.1.2 Global Bacterial Vaccines for Humans Sales by Application (2025-2030)
5.1.3 Global Bacterial Vaccines for Humans Sales Market Share by Application (2019-2030)
5.2 Global Bacterial Vaccines for Humans Revenue by Application (2019-2030)
5.2.1 Global Bacterial Vaccines for Humans Revenue by Application (2019-2024)
5.2.2 Global Bacterial Vaccines for Humans Revenue by Application (2025-2030)
5.2.3 Global Bacterial Vaccines for Humans Revenue Market Share by Application (2019-2030)
5.3 Global Bacterial Vaccines for Humans Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Bacterial Vaccines for Humans Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Bacterial Vaccines for Humans Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Bacterial Vaccines for Humans Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Bacterial Vaccines for Humans Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Bacterial Vaccines for Humans Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Bacterial Vaccines for Humans Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Mitsubishi Tanabe Pharma
6.4.1 Mitsubishi Tanabe Pharma Corporation Information
6.4.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.4.3 Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Product Portfolio
6.4.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Bacterial Vaccines for Humans Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Bacterial Vaccines for Humans Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Bacterial Vaccines for Humans Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bayer Bacterial Vaccines for Humans Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Emergent BioSolutions
6.6.1 Emergent BioSolutions Corporation Information
6.6.2 Emergent BioSolutions Description and Business Overview
6.6.3 Emergent BioSolutions Bacterial Vaccines for Humans Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Emergent BioSolutions Bacterial Vaccines for Humans Product Portfolio
6.7.5 Emergent BioSolutions Recent Developments/Updates
6.8 Walvax
6.8.1 Walvax Corporation Information
6.8.2 Walvax Description and Business Overview
6.8.3 Walvax Bacterial Vaccines for Humans Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Walvax Bacterial Vaccines for Humans Product Portfolio
6.8.5 Walvax Recent Developments/Updates
6.9 Chengdu Kanghua Biological Products Co., Ltd.
6.9.1 Chengdu Kanghua Biological Products Co., Ltd. Corporation Information
6.9.2 Chengdu Kanghua Biological Products Co., Ltd. Description and Business Overview
6.9.3 Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Product Portfolio
6.9.5 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
6.10 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
6.10.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Corporation Information
6.10.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product Portfolio
6.10.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
6.11.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Corporation Information
6.11.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Description and Business Overview
6.11.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product Portfolio
6.11.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Beijing Institute of Biological Products Co., Ltd.
6.12.1 Beijing Institute of Biological Products Co., Ltd. Corporation Information
6.12.2 Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Description and Business Overview
6.12.3 Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Product Portfolio
6.12.5 Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
6.13 CanSino Biological Co., Ltd.
6.13.1 CanSino Biological Co., Ltd. Corporation Information
6.13.2 CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Description and Business Overview
6.13.3 CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Product Portfolio
6.13.5 CanSino Biological Co., Ltd. Recent Developments/Updates
6.14 Hualan Biological Vaccine Co., Ltd.
6.14.1 Hualan Biological Vaccine Co., Ltd. Corporation Information
6.14.2 Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Description and Business Overview
6.14.3 Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Product Portfolio
6.14.5 Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
6.15 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
6.15.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Corporation Information
6.15.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Description and Business Overview
6.15.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Product Portfolio
6.15.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bacterial Vaccines for Humans Industry Chain Analysis
7.2 Bacterial Vaccines for Humans Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bacterial Vaccines for Humans Production Mode & Process
7.4 Bacterial Vaccines for Humans Sales and Marketing
7.4.1 Bacterial Vaccines for Humans Sales Channels
7.4.2 Bacterial Vaccines for Humans Distributors
7.5 Bacterial Vaccines for Humans Customers
8 Bacterial Vaccines for Humans Market Dynamics
8.1 Bacterial Vaccines for Humans Industry Trends
8.2 Bacterial Vaccines for Humans Market Drivers
8.3 Bacterial Vaccines for Humans Market Challenges
8.4 Bacterial Vaccines for Humans Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Bacterial Vaccines for Humans Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Bacterial Vaccines for Humans Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Bacterial Vaccines for Humans Market Competitive Situation by Manufacturers in 2023
Table 4. Global Bacterial Vaccines for Humans Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Bacterial Vaccines for Humans Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Bacterial Vaccines for Humans Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Bacterial Vaccines for Humans Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Bacterial Vaccines for Humans Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Bacterial Vaccines for Humans, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bacterial Vaccines for Humans, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bacterial Vaccines for Humans, Product Type & Application
Table 12. Global Key Manufacturers of Bacterial Vaccines for Humans, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bacterial Vaccines for Humans by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacterial Vaccines for Humans as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bacterial Vaccines for Humans Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Bacterial Vaccines for Humans Sales by Region (2019-2024) & (K Units)
Table 18. Global Bacterial Vaccines for Humans Sales Market Share by Region (2019-2024)
Table 19. Global Bacterial Vaccines for Humans Sales by Region (2025-2030) & (K Units)
Table 20. Global Bacterial Vaccines for Humans Sales Market Share by Region (2025-2030)
Table 21. Global Bacterial Vaccines for Humans Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Bacterial Vaccines for Humans Revenue Market Share by Region (2019-2024)
Table 23. Global Bacterial Vaccines for Humans Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Bacterial Vaccines for Humans Revenue Market Share by Region (2025-2030)
Table 25. North America Bacterial Vaccines for Humans Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Bacterial Vaccines for Humans Sales by Country (2019-2024) & (K Units)
Table 27. North America Bacterial Vaccines for Humans Sales by Country (2025-2030) & (K Units)
Table 28. North America Bacterial Vaccines for Humans Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Bacterial Vaccines for Humans Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Bacterial Vaccines for Humans Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Bacterial Vaccines for Humans Sales by Country (2019-2024) & (K Units)
Table 32. Europe Bacterial Vaccines for Humans Sales by Country (2025-2030) & (K Units)
Table 33. Europe Bacterial Vaccines for Humans Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Bacterial Vaccines for Humans Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Bacterial Vaccines for Humans Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Bacterial Vaccines for Humans Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Bacterial Vaccines for Humans Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Bacterial Vaccines for Humans Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Bacterial Vaccines for Humans Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Bacterial Vaccines for Humans Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Bacterial Vaccines for Humans Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Bacterial Vaccines for Humans Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Bacterial Vaccines for Humans Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Bacterial Vaccines for Humans Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Bacterial Vaccines for Humans Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Bacterial Vaccines for Humans Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Bacterial Vaccines for Humans Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Bacterial Vaccines for Humans Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Bacterial Vaccines for Humans Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Bacterial Vaccines for Humans Sales (K Units) by Type (2019-2024)
Table 51. Global Bacterial Vaccines for Humans Sales (K Units) by Type (2025-2030)
Table 52. Global Bacterial Vaccines for Humans Sales Market Share by Type (2019-2024)
Table 53. Global Bacterial Vaccines for Humans Sales Market Share by Type (2025-2030)
Table 54. Global Bacterial Vaccines for Humans Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Bacterial Vaccines for Humans Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Bacterial Vaccines for Humans Revenue Market Share by Type (2019-2024)
Table 57. Global Bacterial Vaccines for Humans Revenue Market Share by Type (2025-2030)
Table 58. Global Bacterial Vaccines for Humans Price (US$/Unit) by Type (2019-2024)
Table 59. Global Bacterial Vaccines for Humans Price (US$/Unit) by Type (2025-2030)
Table 60. Global Bacterial Vaccines for Humans Sales (K Units) by Application (2019-2024)
Table 61. Global Bacterial Vaccines for Humans Sales (K Units) by Application (2025-2030)
Table 62. Global Bacterial Vaccines for Humans Sales Market Share by Application (2019-2024)
Table 63. Global Bacterial Vaccines for Humans Sales Market Share by Application (2025-2030)
Table 64. Global Bacterial Vaccines for Humans Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Bacterial Vaccines for Humans Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Bacterial Vaccines for Humans Revenue Market Share by Application (2019-2024)
Table 67. Global Bacterial Vaccines for Humans Revenue Market Share by Application (2025-2030)
Table 68. Global Bacterial Vaccines for Humans Price (US$/Unit) by Application (2019-2024)
Table 69. Global Bacterial Vaccines for Humans Price (US$/Unit) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Bacterial Vaccines for Humans Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Merck Bacterial Vaccines for Humans Product
Table 74. Merck Recent Developments/Updates
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Bacterial Vaccines for Humans Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sanofi Bacterial Vaccines for Humans Product
Table 79. Sanofi Recent Developments/Updates
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Bacterial Vaccines for Humans Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. GSK Bacterial Vaccines for Humans Product
Table 84. GSK Recent Developments/Updates
Table 85. Mitsubishi Tanabe Pharma Corporation Information
Table 86. Mitsubishi Tanabe Pharma Description and Business Overview
Table 87. Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Product
Table 89. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Bacterial Vaccines for Humans Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Pfizer Bacterial Vaccines for Humans Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Bayer Corporation Information
Table 96. Bayer Description and Business Overview
Table 97. Bayer Bacterial Vaccines for Humans Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Bayer Bacterial Vaccines for Humans Product
Table 99. Bayer Recent Developments/Updates
Table 100. Emergent BioSolutions Corporation Information
Table 101. Emergent BioSolutions Description and Business Overview
Table 102. Emergent BioSolutions Bacterial Vaccines for Humans Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Emergent BioSolutions Bacterial Vaccines for Humans Product
Table 104. Emergent BioSolutions Recent Developments/Updates
Table 105. Walvax Corporation Information
Table 106. Walvax Description and Business Overview
Table 107. Walvax Bacterial Vaccines for Humans Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Walvax Bacterial Vaccines for Humans Product
Table 109. Walvax Recent Developments/Updates
Table 110. Chengdu Kanghua Biological Products Co., Ltd. Corporation Information
Table 111. Chengdu Kanghua Biological Products Co., Ltd. Description and Business Overview
Table 112. Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Product
Table 114. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
Table 115. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Corporation Information
Table 116. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Description and Business Overview
Table 117. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product
Table 119. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 120. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Corporation Information
Table 121. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Description and Business Overview
Table 122. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product
Table 124. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 125. Beijing Institute of Biological Products Co., Ltd. Corporation Information
Table 126. Beijing Institute of Biological Products Co., Ltd. Description and Business Overview
Table 127. Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Product
Table 129. Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
Table 130. CanSino Biological Co., Ltd. Corporation Information
Table 131. CanSino Biological Co., Ltd. Description and Business Overview
Table 132. CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Product
Table 134. CanSino Biological Co., Ltd. Recent Developments/Updates
Table 135. Hualan Biological Vaccine Co., Ltd. Corporation Information
Table 136. Hualan Biological Vaccine Co., Ltd. Description and Business Overview
Table 137. Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Product
Table 139. Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
Table 140. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Corporation Information
Table 141. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Description and Business Overview
Table 142. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Product
Table 144. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Bacterial Vaccines for Humans Distributors List
Table 148. Bacterial Vaccines for Humans Customers List
Table 149. Bacterial Vaccines for Humans Market Trends
Table 150. Bacterial Vaccines for Humans Market Drivers
Table 151. Bacterial Vaccines for Humans Market Challenges
Table 152. Bacterial Vaccines for Humans Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bacterial Vaccines for Humans
Figure 2. Global Bacterial Vaccines for Humans Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Bacterial Vaccines for Humans Market Share by Type in 2023 & 2030
Figure 4. Meningococcal Vaccine Product Picture
Figure 5. Hib Vaccine Product Picture
Figure 6. BCG Vaccine Product Picture
Figure 7. Typhoid Vaccine Product Picture
Figure 8. Anthrax Vaccine Product Picture
Figure 9. Global Bacterial Vaccines for Humans Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Bacterial Vaccines for Humans Market Share by Application in 2023 & 2030
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Others
Figure 14. Global Bacterial Vaccines for Humans Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Bacterial Vaccines for Humans Market Size (2019-2030) & (US$ Million)
Figure 16. Global Bacterial Vaccines for Humans Sales (2019-2030) & (K Units)
Figure 17. Global Bacterial Vaccines for Humans Average Price (US$/Unit) & (2019-2030)
Figure 18. Bacterial Vaccines for Humans Report Years Considered
Figure 19. Bacterial Vaccines for Humans Sales Share by Manufacturers in 2023
Figure 20. Global Bacterial Vaccines for Humans Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Bacterial Vaccines for Humans Players: Market Share by Revenue in 2023
Figure 22. Bacterial Vaccines for Humans Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Bacterial Vaccines for Humans Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Bacterial Vaccines for Humans Sales Market Share by Country (2019-2030)
Figure 25. North America Bacterial Vaccines for Humans Revenue Market Share by Country (2019-2030)
Figure 26. United States Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Bacterial Vaccines for Humans Sales Market Share by Country (2019-2030)
Figure 29. Europe Bacterial Vaccines for Humans Revenue Market Share by Country (2019-2030)
Figure 30. Germany Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Netherlands Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Bacterial Vaccines for Humans Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Bacterial Vaccines for Humans Revenue Market Share by Region (2019-2030)
Figure 37. China Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Bacterial Vaccines for Humans Sales Market Share by Country (2019-2030)
Figure 45. Latin America Bacterial Vaccines for Humans Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Bacterial Vaccines for Humans Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Bacterial Vaccines for Humans Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Bacterial Vaccines for Humans Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Bacterial Vaccines for Humans by Type (2019-2030)
Figure 55. Global Revenue Market Share of Bacterial Vaccines for Humans by Type (2019-2030)
Figure 56. Global Bacterial Vaccines for Humans Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Bacterial Vaccines for Humans by Application (2019-2030)
Figure 58. Global Revenue Market Share of Bacterial Vaccines for Humans by Application (2019-2030)
Figure 59. Global Bacterial Vaccines for Humans Price (US$/Unit) by Application (2019-2030)
Figure 60. Bacterial Vaccines for Humans Value Chain
Figure 61. Bacterial Vaccines for Humans Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
